These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 31310708)

  • 41. Halothane attenuates nitric oxide relaxation of rat aortas by competition for the nitric oxide receptor site on soluble guanylyl cyclase.
    Jing M; Ling GS; Bina S; Hart JL; Muldoon SM
    Eur J Pharmacol; 1998 Jan; 342(2-3):217-24. PubMed ID: 9548389
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chronic hypoxia impairs soluble guanylyl cyclase-mediated pulmonary arterial relaxation in the rat.
    Crawley DE; Zhao L; Giembycz MA; Liu S; Barnes PJ; Winter RJ; Evans TW
    Am J Physiol; 1992 Sep; 263(3 Pt 1):L325-32. PubMed ID: 1357978
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Release of nitric oxide from endothelial cells stimulated by YC-1, an activator of soluble guanylyl cyclase.
    Wohlfart P; Malinski T; Ruetten H; Schindler U; Linz W; Schoenafinger K; Strobel H; Wiemer G
    Br J Pharmacol; 1999 Nov; 128(6):1316-22. PubMed ID: 10578147
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dual role of the L-arginine-ADMA-NO pathway in systemic hypoxic vasodilation and pulmonary hypoxic vasoconstriction.
    Böger R; Hannemann J
    Pulm Circ; 2020; 10(2):2045894020918850. PubMed ID: 32313645
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Vascular consequences of endothelial nitric oxide synthase uncoupling for the activity and expression of the soluble guanylyl cyclase and the cGMP-dependent protein kinase.
    Münzel T; Daiber A; Ullrich V; Mülsch A
    Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1551-7. PubMed ID: 15879305
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Involvement of 3',5'-cyclic inosine monophosphate in cystathionine γ-lyase-dependent regulation of the vascular tone.
    Mitidieri E; Vellecco V; Brancaleone V; Vanacore D; Manzo OL; Martin E; Sharina I; Krutsenko Y; Monti MC; Morretta E; Papapetropoulos A; Caliendo G; Frecentese F; Cirino G; Sorrentino R; d'Emmanuele di Villa Bianca R; Bucci M
    Br J Pharmacol; 2021 Sep; 178(18):3765-3782. PubMed ID: 33931865
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The nitric oxide/soluble cyclic guanylase/cyclic guanosine monophosphate pathway is involved in the cardiovascular effects of a novel α1- and β-adrenoceptor antagonist.
    Kubacka M; Mogilski S; Bednarski M; Raźny K; Sapa J; Waszkielewicz AM; Marona H; Filipek B
    Pharmacology; 2014; 94(5-6):287-95. PubMed ID: 25531925
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Paracrine nitric oxide induces expression of cardiac sarcomeric proteins in adult progenitor cells through soluble guanylyl cyclase/cyclic-guanosine monophosphate and Wnt/β-catenin inhibition.
    De Pauw A; Massion P; Sekkali B; Andre E; Dubroca C; Kmecova J; Bouzin C; Friart A; Sibille C; Gilon P; De Mulder D; Esfahani H; Strapart A; Martherus R; Payen V; Sonveaux P; Brouckaert P; Janssens S; Balligand JL
    Cardiovasc Res; 2016 Oct; 112(1):478-90. PubMed ID: 27520736
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of muscular eNOS in skeletal arteries: Endothelium-independent hypoxic vasoconstriction of the femoral artery is impaired in eNOS-deficient mice.
    Kim HJ; Yoo HY; Lin HY; Oh GT; Zhang YH; Kim SJ
    Am J Physiol Cell Physiol; 2016 Sep; 311(3):C508-17. PubMed ID: 27486092
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The importance of the nitric oxide-cGMP pathway in age-related cardiovascular disease: Focus on phosphodiesterase-1 and soluble guanylate cyclase.
    Golshiri K; Ataei Ataabadi E; Portilla Fernandez EC; Jan Danser AH; Roks AJM
    Basic Clin Pharmacol Toxicol; 2020 Aug; 127(2):67-80. PubMed ID: 31495057
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Soluble guanylate cyclase-alpha1 deficiency selectively inhibits the pulmonary vasodilator response to nitric oxide and increases the pulmonary vascular remodeling response to chronic hypoxia.
    Vermeersch P; Buys E; Pokreisz P; Marsboom G; Ichinose F; Sips P; Pellens M; Gillijns H; Swinnen M; Graveline A; Collen D; Dewerchin M; Brouckaert P; Bloch KD; Janssens S
    Circulation; 2007 Aug; 116(8):936-43. PubMed ID: 17679618
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Xyloketal B exerts antihypertensive effect in renovascular hypertensive rats via the NO-sGC-cGMP pathway and calcium signaling.
    Zhao LY; Li J; Huang XQ; Wang GH; Lv XF; Meng WF; Chen WL; Pang JY; Lin YC; Sun HS; Wang GL; Du YM
    Acta Pharmacol Sin; 2018 May; 39(5):875-884. PubMed ID: 29595193
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antagonism of Forkhead Box Subclass O Transcription Factors Elicits Loss of Soluble Guanylyl Cyclase Expression.
    Galley JC; Durgin BG; Miller MP; Hahn SA; Yuan S; Wood KC; Straub AC
    Mol Pharmacol; 2019 Jun; 95(6):629-637. PubMed ID: 30988014
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Increased nitrovasodilator sensitivity in endothelial nitric oxide synthase knockout mice: role of soluble guanylyl cyclase.
    Brandes RP; Kim D; Schmitz-Winnenthal FH; Amidi M; Gödecke A; Mülsch A; Busse R
    Hypertension; 2000 Jan; 35(1 Pt 2):231-6. PubMed ID: 10642303
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Protamine does not affect the formation of cGMP or cAMP in pig vascular smooth muscle cells in response to vasodilators.
    Castresana MR; Zhang LM; Newman WH
    Crit Care Med; 1995 May; 23(5):939-43. PubMed ID: 7736754
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Riociguat versus sildenafil on hypoxic pulmonary vasoconstriction and ventilation/perfusion matching.
    Chamorro V; Morales-Cano D; Milara J; Barreira B; Moreno L; Callejo M; Mondejar-Parreño G; Esquivel-Ruiz S; Cortijo J; Cogolludo Á; Barberá JA; Perez-Vizcaino F
    PLoS One; 2018; 13(1):e0191239. PubMed ID: 29364918
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hypoxic contraction of canine coronary arteries: role of endothelium and cGMP.
    Gräser T; Vanhoutte PM
    Am J Physiol; 1991 Dec; 261(6 Pt 2):H1769-77. PubMed ID: 1661088
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differential relaxing responses to particulate or soluble guanylyl cyclase activation on endothelial cells: a mechanism dependent on PKG-I alpha activation by NO/cGMP.
    Rivero-Vilches FJ; de Frutos S; Saura M; Rodriguez-Puyol D; Rodriguez-Puyol M
    Am J Physiol Cell Physiol; 2003 Oct; 285(4):C891-8. PubMed ID: 12814915
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Endothelium-dependent blunting of myogenic responsiveness after chronic hypoxia.
    Earley S; Walker BR
    Am J Physiol Heart Circ Physiol; 2002 Dec; 283(6):H2202-9. PubMed ID: 12388297
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Role of sulfhydryl-dependent dimerization of soluble guanylyl cyclase in relaxation of porcine coronary artery to nitric oxide.
    Zheng X; Ying L; Liu J; Dou D; He Q; Leung SW; Man RY; Vanhoutte PM; Gao Y
    Cardiovasc Res; 2011 Jun; 90(3):565-72. PubMed ID: 21248051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.